MIAMI, Oct. 9, 2008 (GLOBE NEWSWIRE) -- Galea Life Sciences Inc. (Pink Sheets:GLSN) announced today that the company has accepted an offer of settlement with the U.S. Securities and Exchange Commission (SEC) in connection with an administrative proceeding instituted pursuant to Section 12(j) of the Securities and Exchange Act of 1934. This will result in revocation of the registration of each class of GLSN securities, and therefore, halt trading of the Company's stock.
